Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- Check3 days agoChange DetectedA new revision label, v3.5.5, appears on the history page as the latest entry. This marks a minor platform update rather than a change to study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a new version entry on 2026-05-18 with an updated Study Status. An older entry from 2026-04-20 was removed, updating the version history to reflect the latest status change in the record.SummaryDifference0.2%

- Check24 days agoChange DetectedA new revision entry labeled v3.5.4 appears in the record history, replacing the prior v3.5.3. This reflects a minor site-build update to the page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe Record History gains a new revision labeled v3.5.3, replacing the previous v3.5.2 in the visible history.SummaryDifference0.1%

- Check46 days agoChange DetectedThe record history reflects a new version dated 2026-04-20 with an update to the study status, while a prior entry dated 2026-03-19 is removed.SummaryDifference0.2%

- Check53 days agoChange DetectedFooter shows a new site revision (v3.5.2), replacing the previous (v3.5.0). This update is limited to metadata and does not modify study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.